A GINECO phase II study of Navitoclax (ABT 263) in women with platinum resistant/refractory recurrent ovarian cancer (ROC)

Affiliation auteurs!!!! Error affiliation !!!!
TitreA GINECO phase II study of Navitoclax (ABT 263) in women with platinum resistant/refractory recurrent ovarian cancer (ROC)
Type de publicationJournal Article
Year of Publication2017
AuteursBrachet P.E, Fabbro M., Leary A., Medioni J., Follana P., Lesoin A., Frenel J-S., S. Lacourtoisie A, Floquet A., Gladieff L., You B., Gavoille C., Kalbacher E., Briand M., Just P-A., Blanc-Fournier C., Leconte A., Lequesne J., Poulain L., F. Lobbedez J
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534